Landmark study evaluates use of AliveCor Heart Monitor in community screening for atrial fibrillation
I call this study “landmark” not because of some ground breaking discovery or even because of the efficacy of the intervention. Rather, I consider it landmark because it is a pretty well done and carefully crafted study to evaluate the efficacy of a novel mobile health technology in the real world. Like any study, there are a variety of strengths and limitations to be considered when interpreting the results.
That being said, we have written many times about a need for thoughtful evaluation of these technologies to help guide clinicians about their use in practice and that’s precisely what we have here.
TO SEE REST OF ARTICLE, GO TO IMEDICALAPPS.COM